Skip to main content

Stress Incontinence clinical trials at UCLA

1 research study open to eligible people

Showing trials for
  • Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence

    open to eligible females ages 18 years and up

    This study evaluates the efficacy and safety of Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDC-USR; generic name: iltamiocel) compared to a placebo in the reduction of stress incontinence episode frequency in adult female patients with post-surgical persistent or recurrent stress urinary incontinence (SUI). Half of the participants will receive AMDC-USR (injections with cells) and the other half will receive placebo.

    Los Angeles, California and other locations

Our lead scientists for Stress Incontinence research studies include .

Last updated: